Bio-Rad Laboratories, Inc. (BIO.B) vs Haemonetics Corporation (HAE)
- Bio-Rad Laboratories, Inc. BIO.B 364.15 −0.25%
- Haemonetics Corporation HAE 118.28 −2.48%
Bio-Rad Laboratories, Inc. and Haemonetics Corporation are both Medical Devices companies. Bio-Rad Laboratories, Inc. is the larger, with a market value of $10.3B against $5.5B — 1.9× the size. Bio-Rad Laboratories, Inc. trades at the lower P/E: 43.7× against 57.7×. Bio-Rad Laboratories, Inc. grew revenue faster over the last twelve months: 1.37% against 0.44%. Bio-Rad Laboratories, Inc. has the higher net margin (8.59% vs 7.12%) and the lower return on invested capital (0.49% vs 5.62%). Across the 22 metrics below, Bio-Rad Laboratories, Inc. leads on 11 and Haemonetics Corporation on 11.
Valuation
Profitability
| Metric | BIO.B | HAE | Medical Devices median |
|---|---|---|---|
| Gross margin | 51.90% | 59.03% | 56.01% |
| Operating margin | 2.05% | 11.86% | (15.03%) |
| Net margin | 8.59% | 7.12% | (20.40%) |
| Free cash flow margin | 13.64% | 21.64% | (7.24%) |
| Return on equity | 3.11% | 11.20% | (15.32%) |
| Return on assets | 2.17% | 3.99% | (19.72%) |
| Return on invested capital | 0.49% | 5.62% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack